Scinai Immunotherapeutics (SCNI) Receivables (2015 - 2026)
Scinai Immunotherapeutics (SCNI) reported Receivables of $500.0 million for Q1 2026, up 105.76% sequentially from $243.0 million in Q4 2025.
Scinai Immunotherapeutics (SCNI) Receivables (2015 - 2026) Analysis & Trends
Scinai Immunotherapeutics (SCNI) has 12 years of Receivables data on file, last reported at $500.0 million in Q1 2026.
- For the quarter ending Q1 2026, Receivables changed N/A year-over-year to $500.0 million; the trailing twelve-month figure through Mar 2026 stood at $500.0 million (changed N/A YoY), and the FY2025 full-year result was $243.0 million, up 81994.59% from the prior year.
- Receivables improved to $500.0 million in Q1 2026, from $243.0 million in the prior quarter.
- In the past five years, Receivables ranged from a high of $500.0 million in Q1 2026 to a low of $73000.0 in Q1 2022.
- A 5-year average of $74.6 million and a median of $409000.0 in 2024 frame the typical range for Receivables.
- Across the five-year window, Receivables plunged 99.99% in 2022 and soared 81994.59% in 2025, its largest moves.
- Tracing SCNI's Receivables over 5 years: stood at $298000.0 in 2022, then jumped by 97.65% to $589000.0 in 2023, then tumbled by 49.75% to $296000.0 in 2024, then soared by 81994.59% to $243.0 million in 2025, then surged by 105.76% to $500.0 million in 2026.
- Business Quant data shows SCNI's Receivables at $500.0 million in Q1 2026, $243.0 million in Q4 2025, and $375000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 4.97 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 938.02 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 1.13 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.00 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.73 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.93 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Scinai Immunotherapeutics | 352,860.00 | -3.11 Bn | -1.12 Mn | 500.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 500.00 Mn |
| Dec 31, 2025 | 243.00 Mn |
| Jun 30, 2025 | 375,000.00 |
| Dec 31, 2024 | 296,000.00 |
| Sep 30, 2024 | 448,000.00 |
| Jun 30, 2024 | 443,000.00 |
| Dec 31, 2023 | 589,000.00 |
| Sep 30, 2022 | 298,000.00 |
| Jun 30, 2022 | 294,000.00 |
| Mar 31, 2022 | 73,000.00 |
| Dec 31, 2021 | 651,000.00 |
| Sep 30, 2021 | 442,000.00 |
| Jun 30, 2021 | 2.64 Bn |
| Mar 31, 2021 | 481.00 Mn |
| Dec 31, 2020 | 1.20 Bn |
| Sep 30, 2020 | 851,000.00 |
| Jun 30, 2020 | 2.47 Bn |
| Mar 31, 2020 | 1.54 Bn |
| Dec 31, 2019 | 190,000.00 |
| Sep 30, 2019 | 542,000.00 |